Lymphedema: An Overview for PT and OT Providers
Tracking # 20-1125076
Course overview
Complete decongestive therapy for lymphedema requires additional training and certification. However, physical and occupational therapy professionals often treat patients with lymphedema for other impairments, so it is important to understand the impact of lymphedema on the course of care. This course introduces clinicians to their role in effective patient management. Learners will be able to identify the early signs and symptoms of lymphedema, the interaction of lymphedema with clinical presentation and progression, when to refer a patient to a specialist, and how to introduce or reinforce patient self-management techniques.
Subject areas
This course counts toward the state boards and subject areas below.
Alabama State Board of Occupational Therapy
Occupational Therapist
Occupational Therapy Assistant
Arizona Board of Occupational Therapy Examiners
Occupational Therapist
Occupational Therapy Assistant
Arizona State Board of Physical Therapy
Physical Therapist
Physical Therapy Assistant
Florida Board of Physical Therapy Practice
Physical Therapist
Physical Therapist Assistant
Georgia State Board of Occupational Therapy
Occupational Therapist
Occupational Therapy Assistant
Louisiana State Board of Medical Examiners - Occupational Therapy
Occupational Therapist
Occupational Therapy Assistant
MSDOH Bureau of Professional Licensure - Occupational Therapists
Occupational Therapist
Occupational Therapy Assistant
Mississippi State Board of Physical Therapy
Physical Therapist
Physical Therapist Assistant
South Carolina Board of Occupational Therapy
Occupational Therapist
Occupational Therapy Assistant
South Carolina Board of Physical Therapy
Physical Therapist
Physical Therapy Assistant
Tennessee Board of Occupational Therapy
Occupational Therapist
Occupational Therapy Assistant
Disclosure statements
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.